These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 185873)

  • 1. The insulin receptor in normal and obese persons.
    Beck-Nielsen H; Pedersen O; Bagger JP; Sorensen NS
    Acta Endocrinol (Copenh); 1976 Nov; 83(3):565-75. PubMed ID: 185873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells.
    Burman KD; Latham KR; Djuh YY; Smallridge RC; Tseng YC; Lukes YG; Maunder R; Wartofsky L
    J Clin Endocrinol Metab; 1980 Jul; 51(1):106-16. PubMed ID: 6247359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.
    Olefsky JM
    J Clin Invest; 1976 May; 57(5):1165-72. PubMed ID: 177453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptors in human mononuclear leucocytes. II. Binding and degradation of insulin in obese subjects.
    Bellomo G; Bellazzi R; Vittadini G; Fratino P
    Boll Soc Ital Biol Sper; 1979 Apr; 55(7):661-7. PubMed ID: 399190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of insulin receptors in human mononuclear leucocytes.
    Pedersen O; Beck-Nielsen H
    Acta Endocrinol (Copenh); 1976 Nov; 83(3):556-64. PubMed ID: 185872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss.
    Havel PJ; Kasim-Karakas S; Mueller W; Johnson PR; Gingerich RL; Stern JS
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4406-13. PubMed ID: 8954050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid receptors in mononuclear leucocytes of obese subjects.
    Vettor R; Macor C; Novo F; Gottardo C; Zovato S; Simoncini M; Federspil G; Armanini D
    J Endocrinol; 1998 Jan; 156(1):187-94. PubMed ID: 9496248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral glucose on the leucocyte sodium pump in normal and obese subjects.
    Ng LL; Hockaday TD
    Clin Endocrinol (Oxf); 1987 Sep; 27(3):345-53. PubMed ID: 2448070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
    Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiposity, anthropometric measures, and plasma insulin levels of rhesus monkeys.
    Jen KL; Hansen BC; Metzger BL
    Int J Obes; 1985; 9(3):213-24. PubMed ID: 3902688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction.
    Archer JA; Gorden P; Roth J
    J Clin Invest; 1975 Jan; 55(1):166-74. PubMed ID: 1109176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.
    Dandona P; Aljada A; Ghanim H; Mohanty P; Tripathy C; Hofmeyer D; Chaudhuri A
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5043-7. PubMed ID: 15472203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
    Dunaif A; Segal KR; Futterweit W; Dobrjansky A
    Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Mar; 66(3):489-94. PubMed ID: 3127415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.
    Conover CA; Lee PD; Kanaley JA; Clarkson JT; Jensen MD
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1355-60. PubMed ID: 1375600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fasting on serum leptin in normal human subjects.
    Boden G; Chen X; Mozzoli M; Ryan I
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3419-23. PubMed ID: 8784108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.